Kenneth J. Hillan - 20 Feb 2023 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Issuer symbol
ME
Transactions as of
20 Feb 2023
Net transactions value
-$15,662
Form type
4
Filing time
22 Feb 2023, 16:12:54 UTC
Previous filing
23 Dec 2022
Next filing
23 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability $15,662 -5,457 -2.8% $2.87 191,705 20 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on February 17, 2023, the fair market used for the transaction date.